Together, we are all trying to build our fortune by finding well-run companies at bargain-basement prices. But it takes work -- scouring company earnings reports, scrutinizing key data, and assessing the competition.

Because of that, we've created a screen based on the massive data aggregated from the more than 140,000 investors competing on our Motley Fool CAPS platform. Each quarter, we check in on select companies after they file a 10-Q and track community sentiment -- so you can see how your company is doing.

Here's the community sentiment on RXi Pharmaceuticals Corp. (NASDAQ:RXII) both this quarter and last (for comparison), as well as opinions on some related companies.

Metric RXi Pharmaceuticals Corp. (NASDAQ:RXII) Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Genomic Health, Inc. (NASDAQ:GHDX) Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
This Quarter (11/16/2009):
Price: $2.18 $17.44 $19.48 $3.87
% of Members Rating Outperform 83% 93% 93% 93%
% of All-Star Members Rating Outperform 100% 88% 92% 95%
CAPS Rating (out of 5) 0 Stars 3 Stars 3 Stars 3 Stars
Last Quarter (8/18/2009):
Price: $3.18 $21.24 $19.97 $2.92
% of Members Rating Outperform 83% 92% 94% 92%
% of All-Star Members Rating Outperform 67% 90% 96% 94%
CAPS Rating (out of 5) 0 Stars 4 Stars 4 Stars 2 Stars

Source: Motley Fool CAPS. Dates given are the posting dates of RXi Pharmaceuticals Corp.'s most recent quarterly and/or annual reports to the SEC's website. Percentages are calculated from the number of members rating each company.

A change in the community's approval (signified by four- and five-star ratings) or disapproval (one- and two-star ratings) could indicate that further research is in order. To help make your research easier …

  • Share any thoughts you have about RXi Pharmaceuticals Corp. -- or any of the other companies mentioned -- in the comments box below.
  • Head over to the completely free CAPS service -- a one-stop research shop -- and read what your fellow investors are saying about your stocks.


As this was built out of a screen, no individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today's market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Hidden Gems, Motley Fool Pro, and Ready Made Millionaire services) have positions in these stocks. We thought you'd like to know that. Learn more about The Motley Fool's disclosure policy.